Navigation Links
Long-Term Statin Use Won't Up Cancer Risk: Study
Date:11/18/2010

By Amanda Gardner
HealthDay Reporter

THURSDAY, Nov. 18 (HealthDay News) -- New research supports the notion that patients who take cholesterol-lowering drugs known as statins may not have an increased risk for cancer, as some previous studies suggested.

Statins are the most commonly prescribed drugs for people with high blood cholesterol levels, which are linked to heart disease. Brand names include Crestor, Lipitor and Zocor.

"Three or four years ago there was a flare of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr. Valentin Fuster, past president of the American Heart Association and director of Mount Sinai Heart in New York City.

This latest study, slated for presentation Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc., a company that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a division of General Electric, which provided the database for the study.

Another recent study, reported Nov. 10 at a meeting of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even decrease users' risks for lymphoma, melanoma and endometrial tumors.

But while research showed that short-term use of statins had little effect on the risk of developing cancer, less was known about their long-term use.

To get a clearer picture over time, the authors of this new study pored through more than 11 million patient records over two decades (1990 to early 2009) to identify almost 46,000 comparable pairs of statin and non-statin users.

The pairs were followed for an average of eight years.

Cancer occurred in 11.4 percent of almost 24,000 patients during the studied time frame. Non-statin users had an incidence of 11.1 percent, essentially the same as users.

But there is an inherent problem with studying this subject, pointed out Dr. John C. LaRosa, president of the State University of New York Downstate Medical Center in New York City.

"If statins prolong life and you don't die of heart disease, you're going to die of something else," he said. "How are you going to separate an increased risk of cancer caused by statins from the effect that statins have on coronary disease, allowing you to live longer so that a growing malignancy can declare itself clinically?

"I think we may be coming to an issue that we may never know for sure," he added.

Cancer and heart disease are the leading causes of death in the United States.

More information

Head to the U.S. Centers for Disease Control and Prevention for more on cholesterol.

SOURCES: John C. LaRosa, M.D., president, State University of New York (SUNY) Downstate Medical Center, New York City; Valentin Fuster, M.D., Ph.D., past president, American Heart Association and director, Mount Sinai Heart, New York City; study abstract, Nov. 18, 2010, American Heart Association meeting, Chicago, Ill.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Battlefield camaraderie yields long-term dividends for veterans, study finds
2. Newer cornea transplant surgery shows short- and long-term promise
3. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
4. Clinton Bush Haiti Fund Awards International Medical Corps $500,000 for Emergency Medical Care and Long-Term Rebuilding
5. Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
6. Options to Integrate Health and Long-Term Care for Dual Eligibles
7. Long-Term Use of Osteoporosis Drugs Linked to Fractures
8. Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes
9. Increased radiation dose does not increase long-term side effects for prostate cancer patients
10. Health Care Reform Bill Will Also Improve Long-Term Care
11. Long-Term Breast-Feeding Tied to More Aggressive Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Long-Term Statin Use Won't Up Cancer Risk: Study
(Date:6/27/2016)... ... June 27, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has issued ... from extreme heat at their worksites. Employers with workers exposed to high ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: